The best treatment for CD20+ lymphoma often involves monoclonal antibodies targeting the CD20 protein. Rituximab is the most commonly used monoclonal antibody for B-cell non-Hodgkin lymphomas (NHLs) and nodular lymphocyte-predominant Hodgkin lymphoma (HL). Other options include Obinutuzumab (Gazyva) and Ofatumumab Show Full Answer
This is what has been recommended for me and I am so grateful that Fred Hutch, Seattle, recommended treatment when my local cancer center said treatment for me did not meet their protocols. Breathing a huge sigh of relief and hoping for best with them.. starting next week..